These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33468738)

  • 1. [A Case of Advanced Gastric Cancer with Peritoneal Dissemination after Gastrectomy Successfully Treated with Paclitaxel plus Ramucirumab].
    Miyamoto K; Tadano Y; Itoh R
    Gan To Kagaku Ryoho; 2021 Jan; 48(1):113-114. PubMed ID: 33468738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Advanced Gastric Cancer with Peritoneal Dissemination after Gastrectomy Effectively Treated with Combination Chemotherapy of Ramucirumab and Paclitaxel].
    Muroya T; Wajima N; Kubo N; Yoshida E; Akaishi T; Umetsu S; Yoshida T; Wakasa Y; Sato K; Mitsuhashi Y; Umemura K; Ogasawara H; Hara Y; Hakamada K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2066-2068. PubMed ID: 30692286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Recurrent Gastric Cancer with Grade 3 Proteinuria Caused by Ramucirumab plus Paclitaxel Therapy].
    Kimura Y; Makari Y; Mikami J; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Fujita J; Furukawa H; Yasuda T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1080-1082. PubMed ID: 29394540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
    Hirata K; Hamamoto Y; Ando M; Imamura CK; Yoshimura K; Yamazaki K; Hironaka S; Muro K
    BMC Cancer; 2020 Jun; 20(1):548. PubMed ID: 32532230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis.
    Ishikawa M; Iwasa S; Nagashima K; Aoki M; Imazeki H; Hirano H; Shoji H; Honma Y; Okita N; Takashima A; Kato K; Saruta M; Boku N
    Invest New Drugs; 2020 Apr; 38(2):533-540. PubMed ID: 31264067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Gastrointestinal Perforation in Gastric Cancer during Chemotherapy with Paclitaxel plus Ramucirumab].
    Tanaka T; Ueda T; Sadamitsu T; Yokoyama T; Yoshimura A
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2240-2242. PubMed ID: 32156891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Ramucirumab-Related Small Intestinal Perforation in Gastric Cancer].
    Murase H; Oono R; Yoshida T; Ishihara K; Otomo M; Suzuki Y; Hayashi K; Higuchi K; Yoshinouchi S; Kamiya A; Obata M; Ogawa A; Hayashi M; Park S; Iseki H
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1598-1600. PubMed ID: 35046268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laparoscopic Partial Hepatectomy for the Liver Metastasis of Gastric Cancer after Nab-Paclitaxel plus Ramucirumab Combination Therapy-A Case Report].
    Chuman M; Takahashi Y; Tokito T; Maruyama M; Chino S; Ushiku H; Nakamura K; Naito M; Kondo Y; Yamazaki H; Nishi Y; Hiki N
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2065-2067. PubMed ID: 33468802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Perforation of the Diverticulum of the Appendix during Chemotherapy with Ramucirumab plus Nab-Paclitaxel for Gastric Cancer].
    Kurihara M; Sawazaki S; Kawabe T; Minowa K; Akimoto N; Tsuchiya K; Kato A; Higuchi A; Rino Y; Matsukawa H; Saeki H
    Gan To Kagaku Ryoho; 2021 Oct; 48(10):1293-1295. PubMed ID: 34657068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case of Gastric Cancer with Peritoneal Dissemination Effectively Treated with Ramucirumab and Paclitaxel].
    Seo S; Suzuki T; Misumi T; Tashiro H
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1305-1307. PubMed ID: 29394615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Advanced Gastric Cancer Treated Effectively with Combination Chemotherapy of Paclitaxel plus Ramucirumab].
    Masano Y; Moriyama H; Murata T; Sato B; Usui Y
    Gan To Kagaku Ryoho; 2019 Aug; 46(8):1299-1302. PubMed ID: 31501374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Conversion Surgery for Advanced Gastric Cancer With Multiple Liver Metastases Following Ramucirumab Plus Paclitaxel Combination Treatment.
    Namikawa T; Marui A; Yokota K; Fujieda Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    In Vivo; 2021; 35(5):2929-2935. PubMed ID: 34410989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial.
    Yoshikawa T; Muro K; Shitara K; Oh DY; Kang YK; Chung HC; Kudo T; Chin K; Kadowaki S; Hamamoto Y; Hironaka S; Yoshida K; Yen CJ; Omuro Y; Bai LY; Maeda K; Ozeki A; Yoshikawa R; Kitagawa Y
    JAMA Netw Open; 2019 Aug; 2(8):e198243. PubMed ID: 31373648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Thoracic Aortic Dissection Case during Treatment with Ramucirumab plus Nab-Paclitaxel].
    Nikai H; Akiyama Y; Fujisawa R; Endo F; Baba S; Koeda K; Sasaki A
    Gan To Kagaku Ryoho; 2020 Jun; 47(6):981-983. PubMed ID: 32541179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer.
    Okunaka M; Kotani D; Demachi K; Kawazoe A; Yoshino T; Kawasaki T; Shitara K
    BMC Cancer; 2020 Nov; 20(1):1111. PubMed ID: 33198652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of Stage Ⅳ Gastric Cancer Completely Resected after Successful Second-Line Chemotherapy].
    Kidogami S; Kawada J; Fujita J; Tamura S; Mizuno M; Nakano M; Fukada A; Nagano S; Mokutani Y; Kishimoto T; Hashimoto Y; Hirose H; Yoshioka S; Sasaki Y
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1899-1901. PubMed ID: 36733037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study).
    Nakasya A; Hagiwara Y; Ikoma T; Kurioka Y; Matsumoto T; Yamamoto Y; Tsuduki T; Kajiwara T; Moriwaki T; Nishina T; Yamashita N; Hyodo I
    Int J Clin Oncol; 2022 Apr; 27(4):684-694. PubMed ID: 35089459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical Efficacy and Safety of Nab-Paclitaxel plus Ramucirumab Therapy in Patients with Unresectable Advanced or Recurrent Gastric Cancer].
    Murakami K; Takeno A; Masuzawa T; Imada A; Takase K; Toya K; Yukawa Y; Kawai K; Sakamoto T; Katsura Y; Ohmura Y; Kagawa Y; Hata T; Takeda Y; Murata K
    Gan To Kagaku Ryoho; 2020 Mar; 47(3):493-495. PubMed ID: 32381926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case report of complete response by weekly paclitaxel and 5'-DFUR combination chemotherapy for recurrenced gastric cancer with peritoneal dissemination].
    Nakamura M; Sakata K; Kondo J; Nishimura T; Nagashima Y; Okada T
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2327-9. PubMed ID: 23268066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ramucirumab Beyond Disease Progression After Paclitaxel Plus Ramucirumab in Gastric Cancer: A Phase II Trial.
    Sato Y; Yamashita H; Yagi K; Nomura S; Seto Y
    Anticancer Res; 2024 Jul; 44(7):3125-3131. PubMed ID: 38925825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.